Stocks Down Under Videos
Get a 3-month FREE TRIAL to CONCIERGE now!
Concierge gives you timely BUY and SELL alerts on ASX-listed stocks
Interview with Tim Oldham, CEO of AdAlta (ASX:1AD)
August 7, 2020
We talked with Dr. Tim Oldham about the prospects of AdAlta’s lead compound AD-214 as it enters the clinic for its first Phase 1 study, as well as the power of AdAlta’s i-body drug discovery platform.